Bank of New York Mellon Corp - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,000
-11.1%
42,2700.0%0.00%
Q1 2022$9,000
-47.1%
42,2700.0%0.00%
Q4 2021$17,000
-56.4%
42,2700.0%0.00%
Q3 2021$39,000
-18.8%
42,2700.0%0.00%
Q2 2021$48,000
-76.6%
42,270
-73.9%
0.00%
Q1 2021$205,000
-37.5%
162,035
-4.7%
0.00%
Q4 2020$328,000
+7.5%
169,961
+39.9%
0.00%
Q3 2020$305,000
+76.3%
121,497
+56.4%
0.00%
Q2 2020$173,000
+620.8%
77,682
+384.4%
0.00%
Q3 2019$24,000
-51.0%
16,037
-9.1%
0.00%
Q2 2019$49,00017,6370.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$22,769,0006.37%
CVI Holdings, LLC 1,550,960$3,443,0001.28%
ORACLE INVESTMENT MANAGEMENT INC 3,670,384$8,148,0001.03%
Trellus Management Company, LLC 366,432$813,0000.88%
AWM Investment Company, Inc. 1,550,000$3,441,0000.60%
Samsara BioCapital, LLC 750,000$1,665,0000.54%
Nantahala Capital Management 7,426,368$16,487,0000.50%
Consonance Capital Management LP 3,040,000$6,749,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 1,233,676$2,739,0000.26%
Granite Point Capital Management, L.P. 2,200,000$4,884,0000.25%
View complete list of SOLENO THERAPEUTICS INC shareholders